Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...

[74] Accordingly, some clinical trials have been initiated in SLE, using monoclonal antibodies against IFN-α and its receptor (IFNAR) or using an immune therapy to induce polyclonal anti-IFN-α ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies (aPLs) are at a significantly higher risk of developing diffuse alveolar hemorrhage (DAH), according ...

Prophylactic valaciclovir was effective and prevented herpes zoster in patients with systemic lupus erythematosus receiving ...

The diagnosis of SLE is not always straightforward. The blood tests used as a screening test (such as the antinuclear antibodies and anti-double-stranded DNA antibodies) are not definitive.

In fact, from Merck's $1.3 billion deal to GSK's $850 million investment, the "gold content" of Chinese companies' self-developed TCE bispecific antibodies has already been well proven. The new moves ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Among 95 SLE patients and 71 age- and sex-matched healthy ... the researchers also determined that positivity for three antiphospholipid antibody species ("triple aPL") -- IgG and IgM ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a speculative buy in the market. See more here.